Exploring the 5-Substituted 2-Aminobenzothiazole-Based DNA Gyrase B Inhibitors Active against ESKAPE Pathogens-Reference-Cited by-同舟云学术

Exploring the 5-Substituted 2-Aminobenzothiazole-Based DNA Gyrase B Inhibitors Active against ESKAPE Pathogens

Published:2023-06-28 Issue:27 Volume:8 Page:24387-24395
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Sterle Maša¹^ORCID,Durcik Martina¹^ORCID,Stevenson Clare E. M.²,Henderson Sara R.³^ORCID,Szili Petra Eva⁴,Czikkely Marton⁴,Lawson David M.²,Maxwell Anthony²^ORCID,Cahard Dominique⁵^ORCID,Kikelj Danijel¹,Zidar Nace¹^ORCID,Pal Csaba⁴,Mašič Lucija Peterlin¹^ORCID,Ilaš Janez¹^ORCID,Tomašič Tihomir¹^ORCID,Cotman Andrej Emanuel¹^ORCID,Zega Anamarija¹^ORCID

Affiliation:

1. Faculty of Pharmacy, University of Ljubljana, Aškerčeva Cesta 7, Ljubljana 1000, Slovenia

2. Department of Biochemistry and Metabolism, John Innes Centre, Norwich Research Park, Norwich NR4 7UH, U.K.

3. Institute of Microbiology and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, U.K.

4. Synthetic and Systems Biology Unit, Biological Research Centre, Institute of Biochemistry, Szeged H-6726, Hungary

5. CNRS UMR 6014 COBRA, Normandie Université, Mont Saint Aignan 76821, France

Funder

Javna Agencija za Raziskovalno Dejavnost RS

Biotechnology and Biological Sciences Research Council

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsomega.3c01930

Reference28 articles.

1. Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug-resistant bacterial infections, including tuberculosis. https://www.who.int/publications-detail-redirect/WHO-EMP-IAU-2017.12 (accessed November 10, 2022).

2. The global preclinical antibacterial pipeline

3. Antibiotics in the clinical pipeline in October 2019

4. Analysis of the clinical antibacterial and antituberculosis pipeline

5. Exploiting bacterial DNA gyrase as a drug target: current state and perspectives

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improved N-phenylpyrrolamide inhibitors of DNA gyrase as antibacterial agents for high-priority bacterial strains;European Journal of Medicinal Chemistry;2024-11

2. Development of narrow-spectrum topoisomerase-targeting antibacterials against mycobacteria;European Journal of Medicinal Chemistry;2024-10

3. New N-phenylpyrrolamide inhibitors of DNA gyrase with improved antibacterial activity;RSC Advances;2024